No Data
EUDA Health Halts and Moves to Terminate $10 Million ATM Equity Program
EUDA Health Restores Nasdaq Compliance After Market Value Shortfall
EUDA Health Launches Regenixé IPSC-derived Skin Stem Cell Secretome Mask; Regains Nasdaq Listing Compliance
EUDA Health Regains Compliance With Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
12 Health Care Stocks Moving In Wednesday's Intraday Session
20-F: FY2025 Annual Report